Rare diseases
Investigational molecules
Locations
Back to Portugal31 clinical trials in Ponte De Lima, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PortugalA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
PortugalStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PortugalStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
PortugalA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
PortugalNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
PortugalA study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands
PortugalStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis Who Have Not Responded Well to Previous Biologic Treatments
PortugalStudy of apremilast compared to placebo in children aged 5-17 years with juvenile psoriatic arthritis
PortugalSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
PortugalPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
PortugalA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on rheumatoid arthritis and psoriatic arthritis treatments, evaluating new therapeutic approaches including zasocitinib and sonelokimab for patients who haven't received biological medicines.
Multiple trials are examining both established and experimental treatments for improved patient outcomes.
Comprehensive studies targeting various autoimmune conditions, including Sjögren's Syndrome and Systemic Lupus Erythematosus, with a focus on evaluating new therapeutic options like dazodalibep and upadacitinib.
Research aims to address both systemic manifestations and quality of life improvements.
Studies investigating treatments for Crohn's Disease and Ulcerative Colitis, with particular attention to maintenance therapy and long-term disease management strategies.
Focus on developing sustainable treatment options for chronic inflammatory conditions.
Advanced research into conditions like Giant Cell Arteritis and Systemic Sclerosis, evaluating targeted treatments including secukinumab and HZN-825.
Emphasis on developing specialized treatments for complex medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
